 | • レポートコード：QYR2104Z2195 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、腸疾患検査・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（細菌性疾患、ウイルス性疾患、寄生虫性疾患）、用途別市場規模（病院、研究）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腸疾患検査・治療の市場動向 ・企業の競争状況、市場シェア ・腸疾患検査・治療の種類別市場規模（細菌性疾患、ウイルス性疾患、寄生虫性疾患） ・腸疾患検査・治療の用途別市場規模（病院、研究） ・腸疾患検査・治療の北米市場規模2016-2027（アメリカ、カナダ） ・腸疾患検査・治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腸疾患検査・治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腸疾患検査・治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・腸疾患検査・治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、GlaxoSmithKline、Becton Dickinson、bioMérieux、Sanofi、Bayer Pharma、Bio-Rad、Quest Diagnostics、Trinity Biotech） ・結論 |
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
According to World Health Organization (WHO), around 2.2 million people are killed annually due to food and water-borne diarrheal diseases. There is an impending global demand for better diagnostic and therapeutic options to prevent the deaths from enteric diseases.
Market Analysis and Insights: Global Enteric Disease Testing and Therapeutic Market
The global Enteric Disease Testing and Therapeutic market size is projected to reach US$ 3330.2 million by 2026, from US$ 3014.3 million in 2019, at a CAGR of 1.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enteric Disease Testing and Therapeutic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enteric Disease Testing and Therapeutic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enteric Disease Testing and Therapeutic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enteric Disease Testing and Therapeutic market.
Global Enteric Disease Testing and Therapeutic Scope and Market Size
Enteric Disease Testing and Therapeutic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enteric Disease Testing and Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Bacterial disease
Viral disease
Parasitic diseases
Segment by Application
Hospital
Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bacterial disease
1.2.3 Viral disease
1.2.4 Parasitic diseases
1.3 Market by Application
1.3.1 Global Enteric Disease Testing and Therapeutic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Enteric Disease Testing and Therapeutic Market Perspective (2016-2027)
2.2 Enteric Disease Testing and Therapeutic Growth Trends by Regions
2.2.1 Enteric Disease Testing and Therapeutic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Enteric Disease Testing and Therapeutic Historic Market Share by Regions (2016-2021)
2.2.3 Enteric Disease Testing and Therapeutic Forecasted Market Size by Regions (2022-2027)
2.3 Enteric Disease Testing and Therapeutic Industry Dynamic
2.3.1 Enteric Disease Testing and Therapeutic Market Trends
2.3.2 Enteric Disease Testing and Therapeutic Market Drivers
2.3.3 Enteric Disease Testing and Therapeutic Market Challenges
2.3.4 Enteric Disease Testing and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue
3.1.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue (2016-2021)
3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2016-2021)
3.2 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
3.4 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
3.4.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2020
3.5 Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
3.6 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
3.7 Date of Enter into Enteric Disease Testing and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enteric Disease Testing and Therapeutic Breakdown Data by Type
4.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2016-2021)
4.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2022-2027)
5 Enteric Disease Testing and Therapeutic Breakdown Data by Application
5.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2016-2021)
5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Enteric Disease Testing and Therapeutic Market Size (2016-2027)
6.2 North America Enteric Disease Testing and Therapeutic Market Size by Type
6.2.1 North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
6.2.2 North America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
6.2.3 North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
6.3 North America Enteric Disease Testing and Therapeutic Market Size by Application
6.3.1 North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
6.3.2 North America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
6.3.3 North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
6.4 North America Enteric Disease Testing and Therapeutic Market Size by Country
6.4.1 North America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
6.4.2 North America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Enteric Disease Testing and Therapeutic Market Size (2016-2027)
7.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type
7.2.1 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
7.2.2 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
7.2.3 Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application
7.3.1 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
7.3.2 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
7.3.3 Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
7.4 Europe Enteric Disease Testing and Therapeutic Market Size by Country
7.4.1 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
7.4.2 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size (2016-2027)
8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type
8.2.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application
8.3.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
8.4 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region
8.4.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Enteric Disease Testing and Therapeutic Market Size (2016-2027)
9.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Type
9.2.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
9.2.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
9.2.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
9.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Application
9.3.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
9.3.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
9.3.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
9.4 Latin America Enteric Disease Testing and Therapeutic Market Size by Country
9.4.1 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
9.4.2 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size (2016-2027)
10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type
10.2.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2027)
10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application
10.3.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2027)
10.4 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country
10.4.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Enteric Disease Testing and Therapeutic Introduction
11.1.4 Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Introduction
11.2.4 GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Details
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Introduction
11.3.4 Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Details
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Enteric Disease Testing and Therapeutic Introduction
11.4.4 bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.4.5 bioMérieux Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Introduction
11.5.4 Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Details
11.6.2 Bayer Pharma Business Overview
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Introduction
11.6.4 Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.6.5 Bayer Pharma Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Introduction
11.7.4 Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.7.5 Bio-Rad Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Details
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Introduction
11.8.4 Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.8.5 Quest Diagnostics Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Details
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Introduction
11.9.4 Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021)
11.9.5 Trinity Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bacterial disease
Table 3. Key Players of Viral disease
Table 4. Key Players of Parasitic diseases
Table 5. Global Enteric Disease Testing and Therapeutic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Enteric Disease Testing and Therapeutic Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2016-2021)
Table 9. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2022-2027)
Table 11. Enteric Disease Testing and Therapeutic Market Trends
Table 12. Enteric Disease Testing and Therapeutic Market Drivers
Table 13. Enteric Disease Testing and Therapeutic Market Challenges
Table 14. Enteric Disease Testing and Therapeutic Market Restraints
Table 15. Global Enteric Disease Testing and Therapeutic Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Enteric Disease Testing and Therapeutic Market Share by Players (2016-2021)
Table 17. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2020)
Table 18. Ranking of Global Top Enteric Disease Testing and Therapeutic Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Enteric Disease Testing and Therapeutic Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
Table 22. Date of Enter into Enteric Disease Testing and Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2016-2021)
Table 26. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Enteric Disease Testing and Therapeutic Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2016-2021)
Table 30. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Enteric Disease Testing and Therapeutic Product
Table 65. Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product
Table 70. GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. Becton Dickinson Company Details
Table 73. Becton Dickinson Business Overview
Table 74. Becton Dickinson Enteric Disease Testing and Therapeutic Product
Table 75. Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 76. Becton Dickinson Recent Development
Table 77. bioMérieux Company Details
Table 78. bioMérieux Business Overview
Table 79. bioMérieux Enteric Disease Testing and Therapeutic Product
Table 80. bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 81. bioMérieux Recent Development
Table 82. Sanofi Company Details
Table 83. Sanofi Business Overview
Table 84. Sanofi Enteric Disease Testing and Therapeutic Product
Table 85. Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Bayer Pharma Company Details
Table 88. Bayer Pharma Business Overview
Table 89. Bayer Pharma Enteric Disease Testing and Therapeutic Product
Table 90. Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 91. Bayer Pharma Recent Development
Table 92. Bio-Rad Company Details
Table 93. Bio-Rad Business Overview
Table 94. Bio-Rad Enteric Disease Testing and Therapeutic Product
Table 95. Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 96. Bio-Rad Recent Development
Table 97. Quest Diagnostics Company Details
Table 98. Quest Diagnostics Business Overview
Table 99. Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 100. Quest Diagnostics Recent Development
Table 101. Trinity Biotech Company Details
Table 102. Trinity Biotech Business Overview
Table 103. Trinity Biotech Enteric Disease Testing and Therapeutic Product
Table 104. Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2016-2021) & (US$ Million)
Table 105. Trinity Biotech Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enteric Disease Testing and Therapeutic Market Share by Type: 2020 VS 2027
Figure 2. Bacterial disease Features
Figure 3. Viral disease Features
Figure 4. Parasitic diseases Features
Figure 5. Global Enteric Disease Testing and Therapeutic Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research Case Studies
Figure 8. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 9. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Enteric Disease Testing and Therapeutic Market Share by Regions: 2020 VS 2027
Figure 12. Global Enteric Disease Testing and Therapeutic Market Share by Regions (2022-2027)
Figure 13. Global Enteric Disease Testing and Therapeutic Market Share by Players in 2020
Figure 14. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Enteric Disease Testing and Therapeutic Revenue in 2020
Figure 16. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2016-2021)
Figure 17. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2022-2027)
Figure 18. North America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
Figure 20. North America Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
Figure 21. North America Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
Figure 22. United States Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
Figure 26. Europe Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
Figure 27. Europe Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
Figure 28. Germany Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Region (2016-2027)
Figure 38. China Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
Figure 46. Latin America Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
Figure 47. Latin America Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
Figure 48. Mexico Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Country (2016-2027)
Figure 54. Turkey Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Enteric Disease Testing and Therapeutic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 59. Becton Dickinson Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 60. bioMérieux Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 62. Bayer Pharma Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 63. Bio-Rad Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 64. Quest Diagnostics Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 65. Trinity Biotech Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界の腸疾患検査市場規模・現状・予測（2021年-2027年） Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. The growth is further attributed to rising healthcare expenditure, supportive government initiatives, and augmenting disease …- 世界のPCRベース腸疾患検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global PCR-based Enteric Disease Testing Market The global PCR-based Enteric Disease Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high da…
- 世界の院内感染症検査市場規模・現状・予測（2021年-2027年） Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections…
- 世界の院内感染症検査市場規模・現状・予測（2021年-2027年） Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, b…
- 世界のクローン病診断・治療市場規模・現状・予測（2021年-2027年） Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals. Market Analysis and Insights: Global Crohn…